Noronex Statistics

Total Valuation

Noronex has a market cap or net worth of AUD 8.81 million. The enterprise value is 7.82 million.

Market Cap	8.81M
Enterprise Value	7.82M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Noronex has 628.99 million shares outstanding. The number of shares has increased by 31.92% in one year.

Current Share Class	628.99M
Shares Outstanding	628.99M
Shares Change (YoY)	+31.92%
Shares Change (QoQ)	+6.74%
Owned by Insiders (%)	20.47%
Owned by Institutions (%)	10.59%
Float	368.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.92
PB Ratio	8.96
P/TBV Ratio	9.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.50
EV / Sales	21.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.21

Current Ratio	1.21
Quick Ratio	0.96
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -155.36% and return on invested capital (ROIC) is -85.29%.

Return on Equity (ROE)	-155.36%
Return on Assets (ROA)	-57.29%
Return on Invested Capital (ROIC)	-85.29%
Return on Capital Employed (ROCE)	-280.50%
Weighted Average Cost of Capital (WACC)	7.66%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.50% in the last 52 weeks. The beta is 0.62, so Noronex's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-12.50%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	45.52
Average Volume (20 Days)	1,027,149

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Noronex had revenue of AUD 368,164 and -3.13 million in losses. Loss per share was -0.01.

Revenue	368,164
Gross Profit	368,164
Operating Income	-2.76M
Pretax Income	-3.14M
Net Income	-3.13M
EBITDA	-1.08M
EBIT	-2.76M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 1.01 million in cash and n/a in debt, with a net cash position of 1.01 million or 0.00 per share.

Cash & Cash Equivalents	1.01M
Total Debt	n/a
Net Cash	1.01M
Net Cash Per Share	0.00
Equity (Book Value)	982,276
Book Value Per Share	0.00
Working Capital	258,506

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.68M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-748.38%
Pretax Margin	-852.00%
Profit Margin	n/a
EBITDA Margin	-294.58%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Noronex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.92%
Shareholder Yield	-31.92%
Earnings Yield	-35.55%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Noronex has an Altman Z-Score of -13.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.04
Piotroski F-Score	1